GMP Storage Market

GMP Storage Market Forecast and Outlook 2025 to 2035

The global GMP storage market is projected to reach USD 5,210.0 million by 2035, recording an absolute increase of USD 2,010.0 million over the forecast period. The market is valued at USD 3,200.0 million in 2025 and is set to rise at a CAGR of 5.0% during the assessment period.

The market is expected to grow by approximately 1.6 times during the same period, supported by increasing biopharmaceutical manufacturing activities worldwide, driving demand for advanced storage solutions and increasing investments in specialized cold chain facilities and regulatory compliance management platforms globally. However, high infrastructure costs for specialized storage facilities and complex regulatory requirements may pose challenges to market expansion.

Quick Stats for GMP Storage Market

• GMP Storage Market Value (2025): USD 3,200.0 million
• GMP Storage Market Forecast Value (2035): USD 5,210.0 million
• GMP Storage Market Forecast CAGR: 5.0%
• Leading Facility Type in GMP Storage Market: Cold Storage
• Key Growth Regions in GMP Storage Market: Asia Pacific, North America, and Europe
• Top Players in GMP Storage Market: Thermo Fisher, Lonza, WuXi AppTec, Catalent, Samsung Biologics, Charles River, DHL Life Sciences, Cryoport, Marken, BioLife Solutions

GMP Storage Market Year-over-Year Forecast 2025 to 2035

Between 2025 and 2030, the GMP storage market is projected to expand from USD 3,200.0 million to USD 4,100.0 million, resulting in a value increase of USD 900.0 million, which represents 44.8% of the total forecast growth for the decade. This phase of development will be shaped by rising demand for advanced storage solutions and specialized compliance protocols, product innovation in temperature-controlled systems and monitoring technologies, as well as expanding integration with biopharmaceutical manufacturing platforms and regulatory management systems. Companies are establishing competitive positions through investment in storage infrastructure research and development, high-performance cold chain technologies, and strategic market expansion across biopharma, CRO/CMO, and clinical applications.

From 2030 to 2035, the market is forecast to grow from USD 4,100.0 million to USD 5,210.0 million, adding another USD 1,110.0 million, which constitutes 55.2% of the overall ten-year expansion. This period is expected to be characterized by the expansion of specialized storage formulations, including advanced automation systems and integrated monitoring solutions tailored for specific biopharmaceutical applications, strategic collaborations between storage providers and pharmaceutical companies, and an enhanced focus on regulatory harmonization and operational efficiency practices. The growing emphasis on biologics manufacturing and comprehensive supply chain integrity will drive demand for comprehensive storage solutions across diverse pharmaceutical applications.

GMP Storage Market Key Takeaways

Metric	Value
Market Value (2025)	USD 3,200.0 million
Market Forecast Value (2035)	USD 5,210.0 million
Forecast CAGR (2025–2035)	5.0%

Why is the GMP Storage Market Growing?

The GMP storage market grows by enabling pharmaceutical companies to optimize product storage processes while accessing advanced temperature-controlled technologies without substantial infrastructure modifications. Biopharmaceutical companies and manufacturing institutions face mounting pressure to improve product integrity and comply with strict regulatory requirements, with specialized GMP storage typically providing 99.5-99.9% temperature stability rates comparable to conventional alternatives, making advanced solutions essential for competitive pharmaceutical positioning. The biopharmaceutical industry's need for regulatory compliance and application-specific storage control creates demand for comprehensive storage solutions that can provide superior product protection, maintain consistent performance, and ensure regulatory compliance without compromising product quality or operational requirements.

Government initiatives promoting advanced pharmaceutical manufacturing and specialized biotechnology services drive adoption in biopharma, contract organizations, and clinical applications, where storage intervention has a direct impact on product outcomes and pharmaceutical advancement. However, infrastructure complexity constraints during facility development and the expertise requirements for specialized storage deployment may limit accessibility among smaller pharmaceutical companies and developing regions with limited technical infrastructure for advanced cold chain management systems.

Segmental Analysis

The market is segmented by facility type, end user, and region. By facility type, the market is divided into cold storage, ambient storage, and frozen/ultra low. Based on end user, the market is categorized into biopharma, CRO/CMO, and hospitals/clinical. Regionally, the market is divided into Asia Pacific, Europe, North America, and other key regions.

By Facility Type, the Cold Storage Segment Accounts for a Dominant Market Share

The cold storage segment represents the dominant force in the GMP storage market, capturing approximately 50.0% of total market share in 2025. This established facility category encompasses solutions featuring sophisticated temperature control systems and proven storage compounds, including advanced refrigeration combinations and specialized monitoring modules that enable superior product preservation control and storage management across all pharmaceutical conditions. The cold storage segment's market leadership stems from its superior versatility capabilities, with facilities capable of handling diverse pharmaceutical challenges while maintaining consistent temperature standards and operational reliability across all biopharmaceutical environments.

The ambient storage segment maintains a substantial 30.0% market share, serving pharmaceutical companies who require room temperature approaches with enhanced stability features for non-temperature sensitive applications and specialized pharmaceutical products. These facilities offer reliable storage solutions for stable pharmaceutical operations while providing sufficient preservation capabilities to meet regional quality control and regulatory demands. The frozen/ultra low segment accounts for approximately 20.0% of the market, serving specialized storage applications requiring extreme low-temperature preservation.

Key technological advantages driving the cold storage segment include:

• Advanced refrigeration technologies with integrated temperature control mechanisms that reduce temperature fluctuations and ensure consistent preservation performance
• Multi-product compatibility options allowing simultaneous storage across different pharmaceutical types without cross-contamination
• Enhanced monitoring features, providing optimal temperature tracking while maintaining storage integrity during extended storage periods
• Improved automation capabilities enabling precise environmental control across wide temperature ranges and demanding regulatory requirements

By End User, the Biopharma Segment Accounts for the Largest Market Share

Biopharma dominates the end user segment with approximately 55.0% market share in 2025, reflecting the critical role of biopharmaceutical companies in supporting global drug development and biological product manufacturing operations worldwide. The biopharma segment's market leadership is reinforced by increasing demand for biologics storage, technology advances, and rising requirements for comprehensive storage diversity in pharmaceutical programs across developed and emerging markets.

The CRO/CMO segment represents the contract services category, capturing 25.0% market share through specialized contract research and manufacturing organizations for outsourced storage services, clinical trial support, and contract manufacturing applications. This segment benefits from growing pharmaceutical preference for outsourced storage that meets specific regulatory requirements, cost efficiency standards, and service protocols in competitive pharmaceutical markets.

The hospitals/clinical segment accounts for 20.0% market share, serving specialized applications including clinical trials, hospital pharmacies, and medical research storage across various healthcare sectors.

Key market dynamics supporting end user growth include:

• Biopharma expansion driven by biologics advances and product development, requiring specialized facilities in emerging markets
• CRO/CMO modernization trends require high-quality, standardized storage for service consistency and regulatory compliance
• Integration of clinical technologies enabling precision storage management and monitoring systems
• Growing emphasis on end user diversity driving demand for comprehensive, multi-sector storage solutions

What are the Drivers, Restraints, and Key Trends of the GMP Storage Market?

Increasing biopharmaceutical manufacturing and specialized drug development initiatives create increasing demand for temperature-controlled storage systems, with biologics production expanding by 10-15% annually in major developing countries worldwide, requiring comprehensive cold chain infrastructure.

Government initiatives promoting advanced pharmaceutical manufacturing and specialized biotechnology services drive increased adoption of GMP storage solutions, with many countries implementing comprehensive regulatory goals for pharmaceutical advancement by 2030.

Technological advancements in refrigeration technology and monitoring systems enable more effective and cost-competitive storage solutions that reduce product loss while improving preservation efficacy and regulatory capabilities.

Market restraints include high infrastructure investment costs for specialized storage facilities that can deter new market entrants from developing comprehensive storage capabilities, particularly in developing regions where funding for pharmaceutical infrastructure development remains limited.

Regulatory complexity and compliance requirements pose another significant challenge, as storage facilities demand extensive validation processes and documentation, potentially causing increased operational costs and market entry delays.

Pharmaceutical company education and technical support requirements across different regions create additional operational challenges for facility adoption, demanding ongoing investment in regulatory education and compliance training programs.

Key trends indicate accelerated adoption in Asia-Pacific markets, particularly India and China, where pharmaceutical expansion and manufacturing quality requirements drive comprehensive GMP storage adoption.

Technology integration trends toward automated storage systems with enhanced monitoring, temperature validation, and integrated compliance solutions enable proactive pharmaceutical approaches that optimize efficiency and minimize product risk.

However, the market thesis could face disruption if significant advances in alternative preservation technologies or major changes in pharmaceutical approaches reduce reliance on traditional temperature-controlled storage.

Analysis of the GMP Storage Market by Key Country

Country	CAGR (2025–2035)
India	7.2%
China	6.1%
Brazil	5.0%
Germany	4.8%
USA	4.6%
South Korea	4.4%
Japan	4.3%

The GMP storage market is expanding steadily, with India leading at a 7.2% CAGR through 2035, driven by pharmaceutical manufacturing expansion, government-backed biotechnology programs, and advanced storage facility adoption.

China follows at 6.1%, supported by biopharmaceutical modernization and large-scale manufacturing initiatives. Brazil records 5.0%, reflecting rising adoption of specialized pharmaceutical storage in manufacturing centers.

Germany grows at 4.8%, maintaining leadership in pharmaceutical infrastructure and EU compliance. USA posts 4.6%, anchored by advanced biopharmaceutical facilities and regulatory programs. South Korea advances at 4.4%, emphasizing technology integration, while Japan grows steadily at 4.3%, focusing on advanced pharmaceutical storage standards.

India Leads Global Market Expansion

India demonstrates the strongest growth potential in the GMP storage market with a CAGR of 7.2% through 2035. The country's leadership position stems from pharmaceutical manufacturing expansion, government-backed biotechnology development programs, and increasing pharmaceutical expertise driving the adoption of advanced storage solutions.

Growth is concentrated in major pharmaceutical hubs, including Mumbai, Hyderabad, Bangalore, and Ahmedabad, where pharmaceutical companies and specialized manufacturing centers are implementing advanced storage solutions for enhanced product integrity and regulatory compliance.

Distribution channels through pharmaceutical distributors and manufacturing networks expand deployment across specialized storage projects and comprehensive cold chain initiatives. The country's Make in India program provides policy support for pharmaceutical modernization, including advanced storage facility adoption.

Key market factors:

• Pharmaceutical expansion concentrated in manufacturing hubs and specialized pharmaceutical zones with comprehensive biotechnology development programs
• Government support through pharmaceutical programs and manufacturing infrastructure initiatives
• Comprehensive storage technology ecosystem, including established facility providers with proven track records
• Technology integration featuring advanced refrigeration platforms, monitoring systems, and quality optimization technologies

China Emerges as High-Growth Market

In Beijing, Shanghai, Guangzhou, and Shenzhen, the adoption of comprehensive storage solutions is accelerating across pharmaceutical networks and specialized manufacturing facilities, driven by biopharmaceutical modernization targets and government biotechnology programs. The market demonstrates strong growth momentum with a CAGR of 6.1% through 2035, linked to comprehensive pharmaceutical modernization and increasing focus on specialized storage solutions.

Chinese pharmaceutical companies are implementing advanced storage systems and integrated cold chain platforms to enhance product outcomes while meeting growing demand in expanding biopharmaceutical services and domestic pharmaceutical sectors. The country's Healthy China initiatives create persistent demand for storage solutions, while increasing emphasis on pharmaceutical advancement drives adoption of advanced storage systems.

Key development areas:

• Pharmaceutical facilities and manufacturing centers leading storage technology adoption with comprehensive modernization programs
• Biopharmaceutical channels providing integrated solutions with 95% temperature compliance improvement rates
• Technology partnerships between storage companies and pharmaceutical enterprises are expanding market reach
• Integration of advanced pharmaceutical technologies and comprehensive product integrity management systems

Brazil Shows Strong Regional Leadership

Brazil's market expansion is driven by diverse pharmaceutical demand, including specialized manufacturing centers in São Paulo and Rio de Janeiro, and comprehensive storage adoption across multiple pharmaceutical regions. The country demonstrates promising growth potential with a CAGR of 5.0% through 2035, supported by federal government pharmaceutical investment programs and regional biotechnology development initiatives.

Brazilian pharmaceutical companies face implementation challenges related to infrastructure financing constraints and technical expertise availability, requiring phased deployment approaches and support from international suppliers. However, growing export demands and pharmaceutical requirements create compelling business cases for storage adoption, particularly in manufacturing areas where product integrity has a direct impact on pharmaceutical competitiveness.

Market characteristics:

• Specialized pharmaceutical and biotechnology storage segments showing fastest growth with 30% annual increase in GMP storage utilization
• Regional expansion trends focused in pharmaceutical areas in southeastern and southern states
• Future projections indicate the need for local technical support infrastructure and pharmaceutical storage specialist training programs
• Growing emphasis on pharmaceutical exports and international competitiveness in biotechnology operations

Germany Demonstrates Technology Innovation

The German market leads in advanced storage innovation based on integration with precision pharmaceutical systems and specialized biotechnology technologies for enhanced operational performance. The country shows strong potential with a CAGR of 4.8% through 2035, driven by the modernization of existing pharmaceutical infrastructure and the expansion of specialized manufacturing facilities in major pharmaceutical centers, including Berlin, Munich, Frankfurt, and Hamburg. German pharmaceutical companies are adopting intelligent storage systems for regulatory compliance and product improvement, particularly in regions with advanced pharmaceutical requirements and specialized applications demanding comprehensive storage upgrades. Technology deployment channels through established pharmaceutical distributors and biotechnology management companies expand coverage across pharmaceutical facilities and storage-focused operators.

Leading market segments:

• Specialized pharmaceutical modernization projects in major biotechnology centers are implementing comprehensive storage upgrades
• Pharmaceutical partnerships with technology providers, achieving 98% regulatory compliance improvement rates
• Strategic collaborations between storage companies and pharmaceutical operations are expanding market presence
• Focus on high-performance systems and specialized product integrity requirements

United States Emphasizes Pharmaceutical Modernization

In major pharmaceutical centers including Boston, San Francisco, New Jersey, and North Carolina, pharmaceutical companies are implementing comprehensive storage solutions to modernize existing manufacturing infrastructure and improve product integrity, with documented case studies showing a 40% improvement in storage performance through advanced GMP systems. The market shows strong growth potential with a CAGR of 4.6% through 2035, linked to the ongoing modernization of pharmaceutical facilities, biotechnology networks, and emerging specialized storage projects in major regions. American pharmaceutical companies are adopting intelligent storage and monitoring platforms to enhance product reliability while maintaining quality standards demanded by regulatory authorities and pharmaceutical industries. The country's established pharmaceutical infrastructure creates persistent demand for facility upgrade and modernization solutions that integrate with existing manufacturing systems.

Market development factors:

• Pharmaceutical facilities and biotechnology networks leading storage modernization initiatives across United States
• Pharmaceutical modernization programs providing federal funding support for biotechnology and storage infrastructure upgrades
• Strategic partnerships between American pharmaceutical companies and international storage providers are expanding technical capabilities
• Emphasis on advanced pharmaceutical manufacturing and quality standards compliance across biotechnology applications

South Korea Shows Technology-Driven Growth

South Korea's storage market demonstrates sophisticated implementation focused on advanced pharmaceutical technology and storage optimization, with documented integration of advanced GMP storage systems, achieving 45% improvement in product integrity outcomes across pharmaceutical and biotechnology facilities. The country maintains steady growth momentum with a CAGR of 4.4% through 2035, driven by pharmaceutical facilities' emphasis on biotechnology innovation and continuous improvement methodologies that align with international storage requirements applied to pharmaceutical operations. Major pharmaceutical areas, including Seoul, Busan, Incheon, and Daegu, showcase advanced deployment of storage platforms where preservation systems integrate seamlessly with existing pharmaceutical control systems and comprehensive manufacturing management programs.

Key market characteristics:

• Pharmaceutical facilities and biotechnology centers are driving advanced storage requirements with emphasis on preservation innovation and quality
• Quality management partnerships enabling 99% regulatory compliance with comprehensive monitoring programs
• Technology collaboration between Korean companies and international storage providers is expanding market capabilities
• Emphasis on pharmaceutical innovation and continuous improvement methodologies

Japan Emphasizes Advanced Pharmaceutical Integration

Japan's GMP storage market demonstrates mature and technology-focused landscape, characterized by sophisticated integration of storage systems with existing pharmaceutical infrastructure across manufacturing facilities, biotechnology networks, and specialized pharmaceutical initiatives. Japan's emphasis on advanced pharmaceutical manufacturing and storage standards drives demand for high-reliability storage solutions that support comprehensive biotechnology initiatives and regulatory compliance requirements in pharmaceutical operations. The market benefits from strong partnerships between international storage providers and domestic pharmaceutical leaders, creating comprehensive service ecosystems that prioritize system efficacy and pharmaceutical training programs. Manufacturing centers in major pharmaceutical regions showcase advanced storage implementations where preservation systems achieve 97% efficacy through integrated monitoring programs.

Europe Market Split by Country

The GMP storage market in Europe is projected to grow from USD 620.0 million in Germany in 2025, maintaining a 23.8% market share, supported by extensive specialized pharmaceutical infrastructure, advanced manufacturing facilities, and comprehensive storage networks serving major European markets.

France follows with USD 450.0 million (17.3% share) in 2025, driven by comprehensive pharmaceutical programs in major biotechnology regions implementing advanced storage management systems. The United Kingdom holds USD 400.0 million (15.4% share) through the ongoing development of specialized pharmaceutical facilities and advanced storage networks.

Italy commands USD 330.0 million (12.7%), while Spain accounts for USD 290.0 million (11.2%) in 2025. The Rest of Europe region collectively represents USD 510.0 million (19.6% share), attributed to increasing storage adoption in Nordic countries and emerging Eastern European pharmaceutical facilities implementing advanced storage programs.

Competitive Landscape of the GMP Storage Market

The GMP storage market features approximately 15-20 meaningful players with moderate concentration, where the top three companies control roughly 30-40% of global market share through established storage facility portfolios and extensive pharmaceutical industry relationships. Competition centers on regulatory compliance, storage reliability, and technological innovation rather than price competition alone.

Market leaders include Thermo Fisher, Lonza, and WuXi AppTec, which maintain competitive advantages through comprehensive storage solution portfolios, global facility networks, and deep expertise in the pharmaceutical storage and specialized cold chain sectors, creating high switching costs for customers.

These companies leverage established pharmaceutical company relationships and ongoing regulatory support services to defend market positions while expanding into adjacent storage and integrated pharmaceutical applications.

Challengers encompass Catalent and Samsung Biologics, which compete through specialized storage innovations and strong regional presence in key pharmaceutical markets. Storage specialists, including Charles River, DHL Life Sciences, and Cryoport, focus on specific storage technologies or specialized applications, offering differentiated capabilities in temperature control, logistics services, and application-specific solutions.

Regional players and emerging storage companies create competitive pressure through innovative facilities and rapid service deployment capabilities, particularly in high-growth markets including India and China, where local presence provides advantages in pharmaceutical company support and regulatory compliance.

Market dynamics favor companies that combine advanced storage technologies with comprehensive pharmaceutical services that address the complete product lifecycle from storage facility development through ongoing operational support and compliance management.

Global GMP Storage Market - Stakeholder Contribution Framework

Storage solutions represent a critical pharmaceutical technology that enables biopharmaceutical providers, manufacturing institutions, and storage departments to enhance product integrity and regulatory compliance effectiveness without substantial infrastructure modifications, typically providing 99.5-99.9% temperature stability rates comparable to conventional alternatives while improving pharmaceutical outcomes.

With the market projected to grow from USD 3,200.0 million in 2025 to USD 5,210.0 million by 2035 at a 5.0% CAGR, these solutions offer compelling advantages - superior product outcomes, enhanced storage efficiency, and regulatory compliance capabilities - making them essential for specialized pharmaceutical manufacturing, comprehensive biotechnology operations, and diverse pharmaceutical applications seeking reliable storage solutions.

Scaling market penetration and storage capabilities requires coordinated action across pharmaceutical policy, industry standards, storage providers, cold chain technology providers, and research institutions.

How Governments Could Spur Local Production and Adoption?

• Pharmaceutical Development Programs: Include storage capabilities in national biotechnology development initiatives, providing targeted funding for specialized storage facilities in pharmaceutical regions and supporting local storage companies through innovation grants and development support.
• Tax Policy & R&D Support: Implement accelerated depreciation schedules for storage facility production equipment, provide tax incentives for companies investing in advanced refrigeration and monitoring technologies, and establish favorable research accounting standards that encourage storage adoption over conventional approaches.
• Regulatory Framework Development: Create streamlined storage facility approval processes across specialized and general pharmaceutical applications, establish clear compliance testing frameworks for storage operation, and develop international harmonization protocols that facilitate cross-border storage services.
• Skills Development & Training: Fund vocational programs for storage technicians, pharmaceutical specialists, and biotechnology professionals. Invest in technology transfer initiatives that bridge academic research with commercial storage development and pharmaceutical optimization systems.
• Market Access & Competition: Establish procurement policies that favor advanced storage solutions for government pharmaceutical applications, support small and medium pharmaceutical operations through preferential lending programs, and create regulatory environments that encourage innovation in storage technologies.

How Industry Bodies Could Support Market Development?

• Compliance Standards & Certification: Define standardized performance metrics for storage systems across specialized, general, and integrated pharmaceutical applications, establish universal compliance and safety protocols, and create certification programs for facility performance that pharmaceutical companies can rely on.
• Market Education & Best Practices: Lead messaging that demonstrates storage advantages, emphasizing improved product outcomes, enhanced regulatory effectiveness, and superior integrity compatibility compared to conventional alternatives.
• Technology Integration Standards: Develop interoperability standards for storage systems, comprehensive pharmaceutical compatibility guidelines, and advanced biotechnology platforms, ensuring seamless integration across different pharmaceutical environments and storage requirements.
• Professional Development: Run certification programs for pharmaceutical practitioners, storage specialists, and technical service teams on optimizing storage performance, compliance management, and advanced systems in competitive pharmaceutical markets.

How Manufacturers and Technology Players Could Strengthen the Ecosystem?

• Advanced Storage Development: Develop next-generation facilities with enhanced temperature control capabilities, improved monitoring stability, and application-specific storage features that enhance product reliability while improving pharmaceutical outcomes.
• Intelligence Platforms: Provide comprehensive storage software that integrates temperature monitoring, compliance tracking, predictive modeling, and performance optimization, enabling pharmaceutical companies to maximize facility efficacy and operational efficiency.
• Service & Support Networks: Offer flexible support programs for pharmaceutical operations and storage departments, including technical training options, regulatory consultation services, and performance optimization pathways that keep storage systems current with pharmaceutical demands.
• Research & Development Networks: Build comprehensive R&D capabilities, collaborative storage innovation programs, and pharmaceutical development systems that ensure storage technologies maintain high performance rates and consistent reliability across diverse pharmaceutical environments.

Key Players in the GMP Storage Market

• Thermo Fisher Scientific Inc.
• Lonza Group AG
• WuXi AppTec
• Catalent, Inc.
• Samsung Biologics
• Charles River Laboratories International, Inc.
• DHL Life Sciences
• Cryoport, Inc.
• Marken Ltd.
• BioLife Solutions, Inc.
• FedEx Life Sciences
• UPS Healthcare
• Fisher Bioservices
• Biostor
• Q2 Solutions

Scope of the Report

Items	Values
Quantitative Units (2025)	USD 3,200.0 Million
Facility Type	Cold Storage, Ambient Storage, Frozen/Ultra Low
End User	Biopharma, CRO/CMO, Hospitals/Clinical
Regions Covered	Asia Pacific, Europe, North America, Latin America, Middle East & Africa
Countries Covered	India, China, Brazil, Germany, USA, South Korea, Japan, and 40+ countries
Key Companies Profiled	Thermo Fisher, Lonza, WuXi AppTec, Catalent, Samsung Biologics, Charles River, DHL Life Sciences, Cryoport, Marken, BioLife Solutions
Additional Attributes	Dollar sales by facility type and end user categories; regional adoption trends across Asia Pacific, Europe, and North America; competitive landscape with storage solution providers and pharmaceutical companies; pharmaceutical facility requirements and specifications; integration with advanced biotechnology initiatives and specialized storage platforms

GMP Storage Market by Segments

• Facility Type:

  • Cold Storage
  • Ambient Storage
  • Frozen/Ultra Low

• End User:

  • Biopharma
  • CRO/CMO
  • Hospitals/Clinical

• Region:

  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia & New Zealand
    • ASEAN
    • Rest of Asia Pacific
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Nordic
    • BENELUX
    • Rest of Europe
  • North America
    • United States
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkey
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa